Join a Paid FDA-Governed
Earn up to $1,600
No Medical Insurance or Social Security Needed
HERE IS HOW TO GET STARTED
As a study participant, you play a valuable role in helping to get safe, effective drugs approved for public use.
Because you are such an important part of our studies, we have simplified the steps for participation.
Call 1-818-296-6983 or Click on Join Study Below
This is the first step. All volunteers will be able to review the Informed Consent Form, and the program will be carefully explained by our professional medical team.
Come in for a FREE Medical Exam
After evaluating your particular medical situation, we will invite you into our clinic for a comprehensive and complimentary physical exam.
No Special Requirements
If you meet the physical guidelines of the study, you will be asked to participate. No medical insurance is needed to participate.
Receive Up to $1,600
Participants will be assigned to different groups, where you will be carefully monitored for treatment and safety. As a volunteer, you will earn as much as $1,600 for completing the study.
Click to Join the Respiratory Syncytial Virus Infection Study
WHAT YOU SHOULD KNOW
This professional clinical study, conducted by Clinical Research LA, is a short term trial in which you will intake a promising new medication seeking FDA approval. Depending on the study you join, this medication’s use is intended to effectively treat your medical condition.
This clinical research study is a phase 2 study which means that the Phase 1 study was very promising and the FDA has approved the study to move to phase 2. Phase 1 study included human participants and saw limited adverse reaction issues.
Here is what you can expect regarding these studies:
- Complimentary consultation and health exam
- Complimentary lab reports
- Meets all industry safety guidelines
- Governed & monitored by a central ethics committee
- Free transportation or travel reimbursement
- FDA-Governed
- HIPAA-compliant
- Full confidentiality
- Guaranteed compensation
According to the CDC, Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. RSV infections can be dangerous for certain adults. Each year, it is estimated that more than 177,000 older adults are hospitalized and 14,000 of them die in the United States due to RSV infection. Adults at highest risk for severe RSV infection include:
- Older adults, especially those 60 years and older
- Adults with chronic heart or lung disease
- Adults with weakened immune systems
Older adults who get very sick from RSV may need to be hospitalized. Some may even die. Older adults are at greater risk than young adults for serious complications from RSV because our immune systems weaken when we are older.
Clinical Research LA
A RESPECTED MEDICAL TEAM
Our clinical research clinic has extensive experience conducting Phase II through IV clinical trials with many leading pharmaceutical companies. The facility features multiple investigator with many years in clinical research and counts over 10,000 patients. Every member of the team offers a wealth of experience, a caring personality and a commitment to ably serving the pharmaceutical industry, the community, and its patients.
Our team of clinical research investigators brings many years of research experience working at UCLA and USC. They speak English, Spanish, Italian and Farsi.
Clinical Research LA
22030 Sherman Way
Canoga Park, CA 91303
Call Toll-Free: 1-818-296-6983
Reserve Your Place Now…
Your information is private and secure. It will not be shared or spammed.